Drospirenone; Ethinyl Estradiol; Levomefolate Calcium Patent Expiration

Drospirenone; Ethinyl Estradiol; Levomefolate Calcium is Used for contraception, prevention of pregnancy, and treating mood changes and anxiety in women with PMDD who choose oral contraceptives. It was first introduced by Bayer Healthcare Pharmaceuticals Inc in its drug Beyaz on Sep 24, 2010. Another drug containing Drospirenone; Ethinyl Estradiol; Levomefolate Calcium is Safyral. 3 different companies have introduced drugs containing Drospirenone; Ethinyl Estradiol; Levomefolate Calcium.


Drospirenone; Ethinyl Estradiol; Levomefolate Calcium Patents

Given below is the list of patents protecting Drospirenone; Ethinyl Estradiol; Levomefolate Calcium, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Beyaz US11617751 Pharmaceutical composition containing a tetrahydrofolic acid Jul 17, 2030 Bayer Hlthcare
Safyral US11617751 Pharmaceutical composition containing a tetrahydrofolic acid Jul 17, 2030 Bayer Hlthcare
Beyaz US8617597 Pharmaceutical composition containing a tetrahydrofolic acid Feb 08, 2030 Bayer Hlthcare
Safyral US8617597 Pharmaceutical composition containing a tetrahydrofolic acid Feb 08, 2030 Bayer Hlthcare
Beyaz US7163931 Compositions of estrogen-cyclodextrin complexes Mar 03, 2022

(Expired)

Bayer Hlthcare
Safyral US7163931 Compositions of estrogen-cyclodextrin complexes Mar 03, 2022

(Expired)

Bayer Hlthcare
Beyaz US6958326 Cyclodextrin-drospirenone inclusion complexes Dec 30, 2021

(Expired)

Bayer Hlthcare
Safyral US6958326 Cyclodextrin-drospirenone inclusion complexes Dec 20, 2021

(Expired)

Bayer Hlthcare
Beyaz US6441168 Stable crystalline salts of 5-methyltetrahydrofolic acid Apr 17, 2020

(Expired)

Bayer Hlthcare
Safyral US6441168 Stable crystalline salts of 5-methyltetrahydrofolic acid Apr 17, 2020

(Expired)

Bayer Hlthcare
Beyaz US5798338 Solid dosage forms that contain clathrates of 17α-ethinyl estradiol Jul 10, 2015

(Expired)

Bayer Hlthcare
Safyral US5798338 Solid dosage forms that contain clathrates of 17α-ethinyl estradiol Jul 10, 2015

(Expired)

Bayer Hlthcare
Beyaz USRE37564 Composition for contraception Jun 30, 2014

(Expired)

Bayer Hlthcare
Beyaz USRE37838 Composition for contraception Jun 30, 2014

(Expired)

Bayer Hlthcare
Beyaz USRE38253 Composition for contraception Jun 30, 2014

(Expired)

Bayer Hlthcare
Beyaz USRE43916 Composition for contraception Jun 30, 2014

(Expired)

Bayer Hlthcare



Drospirenone; Ethinyl Estradiol; Levomefolate Calcium's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Drospirenone; Ethinyl Estradiol; Levomefolate Calcium Generic API Manufacturers

Several generic applications have been filed for Drospirenone; Ethinyl Estradiol; Levomefolate Calcium. The first generic version for Drospirenone; Ethinyl Estradiol; Levomefolate Calcium was by Watson Laboratories Inc and was approved on Oct 11, 2016. And the latest generic version is by Lupin Ltd and was approved on Jun 13, 2018.

Given below is the list of companies who have filed for Drospirenone; Ethinyl Estradiol; Levomefolate Calcium generic, along with the locations of their manufacturing plants worldwide.


1. LUPIN LTD

Lupin Ltd has filed for 2 different strengths of generic version for Drospirenone; Ethinyl Estradiol; Levomefolate Calcium. Out of these 3mg,n/a;0.03mg,n/a;0.451mg,0.451mg version comes by the name TYDEMY, 3mg,n/a;0.02mg,n/a;0.451mg,0.451mg version comes by the name DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM. Given below are the details of the strengths of this generic introduced by Lupin Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
3MG,N/A; 0.03MG,N/A; 0.451MG,0.451MG

tablet Prescription ORAL AB Dec 12, 2017
3MG,N/A; 0.02MG,N/A; 0.451MG,0.451MG

tablet Prescription ORAL AB Jun 13, 2018


Manufacturing Plant Locations
New

Lupin Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Lupin Ltd as present at those locations.

Country City Firm Name
India
Aurangabad Lupin Ltd.





2. WATSON LABS INC

Watson Laboratories Inc has filed for 2 different strengths of generic version for Drospirenone; Ethinyl Estradiol; Levomefolate Calcium. All of these versions come by the name DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM. Given below are the details of the strengths of this generic introduced by Watson Labs Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
3MG,N/A; 0.02MG,N/A; 0.451MG,0.451MG

tablet Prescription ORAL AB Oct 11, 2016
3MG,N/A; 0.03MG,N/A; 0.451MG,0.451MG

tablet Prescription ORAL AB Oct 11, 2016